ATX-LPA receptor axis in inflammation and cancer

Shuying Liu, Mandi Murph, Nattapon Panupinthu, Gordon Mills

Research output: Contribution to journalReview article

68 Citations (Scopus)

Abstract

Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) mediates a plethora of physiological and pathological activities via interactions with a series of high affinity G proteincoupled receptors (GPCR). Both LPA receptor family members and autotaxin (ATX/LysoPLD), the primary LPA-producing enzyme, are aberrantly expressed in many human breast cancers and several other cancer lineages. Using transgenic mice expressing either an LPA receptor or ATX, we recently demonstrated that the ATX-LPA receptor axis plays a causal role in breast tumorigenesis and cancer-related inflammation, further validating the ATX-LPA receptor axis as a rich therapeutic target in cancer.

Original languageEnglish (US)
Pages (from-to)3695-3701
Number of pages7
JournalCell Cycle
Volume8
Issue number22
DOIs
StatePublished - Nov 15 2009
Externally publishedYes

Fingerprint

Lysophosphatidic Acid Receptors
Inflammation
Neoplasms
Breast Neoplasms
Transgenic Mice
Carcinogenesis
Enzymes

Keywords

  • ATX
  • Breast cancer
  • Cytokines
  • G protein-coupled receptor
  • Inflammation
  • LPA
  • Target therapy

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Cite this

ATX-LPA receptor axis in inflammation and cancer. / Liu, Shuying; Murph, Mandi; Panupinthu, Nattapon; Mills, Gordon.

In: Cell Cycle, Vol. 8, No. 22, 15.11.2009, p. 3695-3701.

Research output: Contribution to journalReview article

Liu, S, Murph, M, Panupinthu, N & Mills, G 2009, 'ATX-LPA receptor axis in inflammation and cancer', Cell Cycle, vol. 8, no. 22, pp. 3695-3701. https://doi.org/10.4161/cc.8.22.9937
Liu, Shuying ; Murph, Mandi ; Panupinthu, Nattapon ; Mills, Gordon. / ATX-LPA receptor axis in inflammation and cancer. In: Cell Cycle. 2009 ; Vol. 8, No. 22. pp. 3695-3701.
@article{ea963ea283f0466290811ae2301a3193,
title = "ATX-LPA receptor axis in inflammation and cancer",
abstract = "Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) mediates a plethora of physiological and pathological activities via interactions with a series of high affinity G proteincoupled receptors (GPCR). Both LPA receptor family members and autotaxin (ATX/LysoPLD), the primary LPA-producing enzyme, are aberrantly expressed in many human breast cancers and several other cancer lineages. Using transgenic mice expressing either an LPA receptor or ATX, we recently demonstrated that the ATX-LPA receptor axis plays a causal role in breast tumorigenesis and cancer-related inflammation, further validating the ATX-LPA receptor axis as a rich therapeutic target in cancer.",
keywords = "ATX, Breast cancer, Cytokines, G protein-coupled receptor, Inflammation, LPA, Target therapy",
author = "Shuying Liu and Mandi Murph and Nattapon Panupinthu and Gordon Mills",
year = "2009",
month = "11",
day = "15",
doi = "10.4161/cc.8.22.9937",
language = "English (US)",
volume = "8",
pages = "3695--3701",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "22",

}

TY - JOUR

T1 - ATX-LPA receptor axis in inflammation and cancer

AU - Liu, Shuying

AU - Murph, Mandi

AU - Panupinthu, Nattapon

AU - Mills, Gordon

PY - 2009/11/15

Y1 - 2009/11/15

N2 - Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) mediates a plethora of physiological and pathological activities via interactions with a series of high affinity G proteincoupled receptors (GPCR). Both LPA receptor family members and autotaxin (ATX/LysoPLD), the primary LPA-producing enzyme, are aberrantly expressed in many human breast cancers and several other cancer lineages. Using transgenic mice expressing either an LPA receptor or ATX, we recently demonstrated that the ATX-LPA receptor axis plays a causal role in breast tumorigenesis and cancer-related inflammation, further validating the ATX-LPA receptor axis as a rich therapeutic target in cancer.

AB - Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) mediates a plethora of physiological and pathological activities via interactions with a series of high affinity G proteincoupled receptors (GPCR). Both LPA receptor family members and autotaxin (ATX/LysoPLD), the primary LPA-producing enzyme, are aberrantly expressed in many human breast cancers and several other cancer lineages. Using transgenic mice expressing either an LPA receptor or ATX, we recently demonstrated that the ATX-LPA receptor axis plays a causal role in breast tumorigenesis and cancer-related inflammation, further validating the ATX-LPA receptor axis as a rich therapeutic target in cancer.

KW - ATX

KW - Breast cancer

KW - Cytokines

KW - G protein-coupled receptor

KW - Inflammation

KW - LPA

KW - Target therapy

UR - http://www.scopus.com/inward/record.url?scp=70449769732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449769732&partnerID=8YFLogxK

U2 - 10.4161/cc.8.22.9937

DO - 10.4161/cc.8.22.9937

M3 - Review article

C2 - 19855166

AN - SCOPUS:70449769732

VL - 8

SP - 3695

EP - 3701

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 22

ER -